HC Surgical Specialists Limited (SGX:1B1)

Market Cap	57.52M +43.8%
Revenue (ttm)	19.14M -0.8%
Net Income	9.03M +139.2%
EPS	0.06 +139.6%
Shares Out	153.38M
PE Ratio	6.38
Forward PE	n/a
Dividend	0.02 (5.62%)
Ex-Dividend Date	Mar 2, 2026

Volume	13,500
Average Volume	28,775
Open	0.3700
Previous Close	n/a
Day's Range	0.3700 - 0.3700
52-Week Range	0.2700 - 0.3850
Beta	-0.11
RSI	54.67
Earnings Date	Apr 9, 2026

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2015
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 1B1

Financial Performance

In fiscal year 2025, HC Surgical Specialists's revenue was 19.30 million, an increase of 1.77% compared to the previous year's 18.97 million. Earnings were 8.44 million, an increase of 119.42%.